Page last updated: 2024-08-23

enoximone and Cardiomyopathies, Primary

enoximone has been researched along with Cardiomyopathies, Primary in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's4 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beutlhauser, T; Erb, J; Feldheiser, A; Grubitzsch, H; Schuster, B; Spies, C; Treskatsch, S1
Berti, S; Biagini, A; Bonini, R; Clerico, A; Ferrazzi, P; Iascone, MR; Iervasi, G; Manfredi, C; Palmieri, C; Ravani, M1
Robin, NM; Wenstone, R1
Bethke, T; Eschenhagen, T; Klimkiewicz, A; Kohl, C; Mehl, H; Mende, U; Meyer, W; Neumann, J; Rosswag, S; von der Leyen, H1
Beurrier, D; Bock, F; Brembilla-Perrot, B; Danglas, P1
Reddy, PS; Uretsky, BF; Valdes, AM1
Hakki, A; Iskandrian, AS; Likoff, MJ; Ulrich, S1
Bonzel, T; Hasenfuss, G; Heiss, WH; Holubarsch, C; Just, H; Meinertz, T1

Reviews

1 review(s) available for enoximone and Cardiomyopathies, Primary

ArticleYear
Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Circulation, 1986, Volume: 73, Issue:3 Pt 2

    Topics: Administration, Oral; Animals; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Dogs; Enoximone; Heart Failure; Heart Rate; Hemodynamics; Hormones; Humans; Imidazoles; Injections, Intravenous; Kinetics; Lactates; Myocardial Contraction; Time Factors; Vasodilation

1986

Trials

2 trial(s) available for enoximone and Cardiomyopathies, Primary

ArticleYear
Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
    The Journal of international medical research, 2014, Volume: 42, Issue:3

    Topics: Aged; Aged, 80 and over; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Coronary Artery Bypass; Double-Blind Method; Enoximone; Female; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Prospective Studies; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vasoconstrictor Agents; Ventricular Dysfunction, Left

2014
[Electrophysiologic effects of enoximone].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83 Spec No 3

    Topics: Aged; Cardiomyopathies; Cardiotonic Agents; Drug Evaluation; Electrophysiology; Enoximone; Heart Conduction System; Humans; Imidazoles; Middle Aged; Tachycardia; Tachycardia, Supraventricular

1990

Other Studies

5 other study(ies) available for enoximone and Cardiomyopathies, Primary

ArticleYear
Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
    Cardiovascular drugs and therapy, 1996, Volume: 10, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Cardiomyopathies; Cardiotonic Agents; Enoximone; Female; Hemodynamics; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Renal Circulation; Renin

1996
The use of enoximone in peripartum cardiomyopathy.
    Intensive care medicine, 1998, Volume: 24, Issue:9

    Topics: Adult; Cardiomyopathies; Cardiotonic Agents; Enoximone; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular

1998
Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts.
    Arzneimittel-Forschung, 1992, Volume: 42, Issue:4

    Topics: Adult; Cardiomyopathies; Chromatography, DEAE-Cellulose; Enoximone; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain; Phosphodiesterase Inhibitors

1992
Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 1986, Jun-01, Volume: 57, Issue:15

    Topics: Adult; Aged; Cardiomyopathies; Cardiomyopathy, Dilated; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged

1986
Influence of phosphodiesterase inhibition on myocardial energetics in dilative cardiomyopathy.
    Basic research in cardiology, 1987, Volume: 82 Suppl 2

    Topics: Cardiomyopathies; Cardiotonic Agents; Enoximone; Heart; Heart Rate; Humans; Imidazoles; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors

1987